Jorn Drappa's Insider Trades & SAST Disclosures
Jorn Drappa's most recent trade in Alumis Inc. was a trade of 180,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 18, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Jorn Drappa.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Alumis Inc. | Jorn Drappa | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 180,000 | 180,000 | - | - | Stock Option (Right to Buy) | |
| Alumis Inc. | Jorn Drappa | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jun 2024 | 171,122 | 0 | - | - | Stock Option (Right to Buy) | |
| Alumis Inc. | Jorn Drappa | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2024 | 171,122 | 171,122 | - | - | Stock Option (Right to Buy) | |
| Alumis Inc. | Jorn Drappa | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jun 2024 | 85,561 | 0 | - | - | Stock Option (Right to Buy) | |
| Alumis Inc. | Jorn Drappa | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2024 | 85,561 | 85,561 | - | - | Stock Option (Right to Buy) | |
| Alumis Inc. | Jorn Drappa | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jun 2024 | 70,802 | 0 | - | - | Stock Option (Right to Buy) | |
| Alumis Inc. | Jorn Drappa | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2024 | 70,802 | 70,802 | - | - | Common Stock (Right to Buy) | |
| Alumis Inc. | Jorn Drappa | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jun 2024 | 64,171 | 0 | - | - | Stock Option (Right to Buy) | |
| Alumis Inc. | Jorn Drappa | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2024 | 64,171 | 64,171 | - | - | Stock Option (Right to Buy) | |
| Alumis Inc. | Jorn Drappa | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jun 2024 | 54,545 | 0 | - | - | Stock Option (Right to Buy) | |
| Alumis Inc. | Jorn Drappa | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2024 | 54,545 | 54,545 | - | - | Stock Option (Right to Buy) | |
| Alumis Inc. | Jorn Drappa | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jun 2024 | 18,652 | 0 | - | - | Stock Option (Right to Buy) | |
| Alumis Inc. | Jorn Drappa | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2024 | 18,652 | 18,652 | - | - | Stock Option (Right to Buy) | |
| Alumis Inc. | Jorn Drappa | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jun 2024 | 12,834 | 0 | - | - | Stock Option (Right to Buy) | |
| Alumis Inc. | Jorn Drappa | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2024 | 12,834 | 12,834 | - | - | Stock Option (Right to Buy) | |
| Alumis Inc. | Jorn Drappa | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jun 2024 | 5,347 | 0 | - | - | Stock Option (Right to Buy) | |
| Alumis Inc. | Jorn Drappa | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2024 | 5,347 | 5,347 | - | - | Stock Option (Right to Buy) | |
| Alumis Inc. | Jorn Drappa | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2024 | 5,347 | 5,347 | - | - | Stock Option (Right to Buy) | |
| Alpine Immune Sciences Inc | Jorn Drappa | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 20,000 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Jorn Drappa | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 17,500 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Jorn Drappa | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 10,000 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Jorn Drappa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 17,500 | 17,500 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Jorn Drappa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 10,000 | 10,000 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Jorn Drappa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2022 | 20,000 | 20,000 | - | - | Stock Option (Right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges